Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Eloralintide for Sale > Eloralintide, LY3841136, 2883634-40-8
Eloralintide, LY3841136, 2883634-40-8 buy - large image1
Eloralintide, LY3841136, 2883634-40-8 buy - image1

Eloralintide, LY3841136, 2883634-40-8

42 Inquiries

Unit Price:

$1000-1200/G FOB

Get Latest Price
CAS No.:

2883634-40-8

Grade:

Reagent Grade

Content:

98%

Port:

shanghai

Brand:

cellmano

Packaging:

1g

Price valid (until):

2029-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    CAT#:PEP108

    Product Name : Eloralintide

    Synonyms: LY3841136

    CAS#: 2883634-40-8

    Molecular Formula: C201H319N49O65S2

    MW: 4526.10

    Sequence:H-γ-Glu-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gly-Orn-Leu-Ala-Glu-(α-Me-Phe)-Leu-Val-Arg-Ser-Ser-Asn-(N-Me-Asn)-Phe-Gly-Pro-Lys(γGlu-γGlu-C20 diacid)-Leu-Pro-Pro-Thr-Glu-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (Disulfide bridge:Cys2-Cys7)

    Appearance: white powder

    Purity (HPLC):≥98.0%

    Single Impurity (HPLC): ≤1.0%

    Acetate Content(HPLC):≤12.0%

    Water Content (Karl Fischer): ≤10.0%

    Peptide content: ≥80.0%

    Package:1g-1kg in plastic bottle

    Storage:2-8 degree, store in dry and cool place

    Usage: used for R&D only

    Shop Eloralintide, LY3841136, 2883634-40-8-Detailed Image 1

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide

    Location:

    Room C608, Chiyuan venture park

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    10

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

        Cellmano Biotech Limited focus on researching and developing solid phase peptide synthesis methodology since 2011. Cellmano has 10 years experience in researching, developing and manufacturing peptides by solid peptide phase synthesis. 
        Cellmano  not only provides  cosmeceuticals peptide & generic peptides to the customers, but also offer peptide CMO service and custom peptides synthesis service depend on the requirement from the customers over the world. Cellmano has state-of-the-art labs armed with excellent instrument for synthesis, purify and analysis .Cellmao control the quality by checking the materials, supervising produce process and finally QC. Cellmano keep all the synthesis records , purify methods and analysis result for every batch peptide product with staff and time invovled in the archives. Synthesizing by classical solid phase mothed invented by Prof.Bruce Merrified and purifying by HPLC instrument, Cellmano supply the customers excellent peptide products with reasonable price ,while maintain high quality, to help the customers to cut down their cost and shorten the time . Cellmano is trying her best to complement the inventory  for more than 2000 popular peptide products, to make sure the customers can get what they need in one week from Cellmano’s inventory. Also to saitisfy diverse request from different customers for different projects, Cellmano provide custom synthesis for  peptides from mgs to kgs with the purity from crude to 98% .


  • Inquiry History
    42 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    United States

    eloralintide

    1 PCS Jul 26, 2026
    Australia

    Eloralintide

    15 MG Jul 20, 2026
    United States

    Eloralintide

    1 MT Jul 15, 2026
    United States

    Eloralintide

    20 MG Jul 13, 2026
    United States

    Eloralintide

    Jul 4, 2026
    United States

    Eloralintide

    100 MT Jun 29, 2026
    United States

    Elorintide

    15 MG Jun 15, 2026
    United States

    (LY3841136)

    1000 MG Jun 8, 2026
    Australia

    Eloralintide

    100 MT May 8, 2026
    Thailand

    Eloralintide

    2 G Mar 30, 2026
    United States

    Eloralintide

    Mar 9, 2026
    United States

    Eloralintide

    2 G Feb 7, 2026
    United States

    Eloralintide

    10 PCS Nov 11, 2025
    United States

    Eloralintide

    2 PCS Aug 2, 2026
    United States

    Eloralintide

    10 PCS Jul 30, 2026
    United States

    Eloralintide

    20 MT Jul 23, 2026
    United States

    Eloralintide

    10 MG Jul 15, 2026
    United States

    Eloralintide

    100 MT Jul 11, 2026
    United States

    Eloralintide

    1 MT Jul 8, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.